Femasys (FEMY) Shares Outstanding (Weighted Average) (2020 - 2026)

Femasys (FEMY) reported Shares Outstanding (Weighted Average) of $66.6 million for Q1 2026, up 165.0% on a YoY basis from $25.1 million in Q1 2025, and down 11.63% quarter-over-quarter from $75.4 million in Q4 2025.

Femasys (FEMY) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends

Femasys has reported Shares Outstanding (Weighted Average) for 7 years, with the latest figure at $66.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 165.0% year-over-year to $66.6 million; the trailing twelve-month figure through Mar 2026 stood at $66.6 million (up 165.0% YoY), and the FY2025 full-year result was $75.4 million, up 238.68% from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 stood at $66.6 million, down from $75.4 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $75.4 million in Q4 2025, with the low at $11.8 million in Q1 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $24.4 million across 5 years, with a median of $21.8 million in 2024.
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) jumped 1086.1% — and 2023, when it rose 0.58%.
  • Femasys' Shares Outstanding (Weighted Average) stood at $11.8 million in 2022, then surged by 30.21% to $15.4 million in 2023, then surged by 44.74% to $22.3 million in 2024, then surged by 238.68% to $75.4 million in 2025, then decreased by 11.63% to $66.6 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $66.6 million (Q1 2026), $75.4 million (Q4 2025), and $31.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 354.90 Mn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 283.14 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 819.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 145.34 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 72.00 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 174.20 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn 195.40 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 71.43 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 515.00 Mn
10 Femasys 254.59 Mn 249.20 Mn - 66.65 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 66.65 Mn
Dec 31, 2025 75.42 Mn
Sep 30, 2025 31.74 Mn
Jun 30, 2025 27.03 Mn
Mar 31, 2025 25.15 Mn
Dec 31, 2024 22.27 Mn
Sep 30, 2024 22.08 Mn
Jun 30, 2024 22.22 Mn
Mar 31, 2024 21.78 Mn
Dec 31, 2023 15.38 Mn
Sep 30, 2023 13.37 Mn
Jun 30, 2023 12.49 Mn
Mar 31, 2023 11.87 Mn
Dec 31, 2022 11.82 Mn
Sep 30, 2022 11.81 Mn
Jun 30, 2022 11.81 Mn
Mar 31, 2022 11.80 Mn
Dec 31, 2021 6.71 Mn
Sep 30, 2021 5.00 Mn
Jun 30, 2021 2.08 Mn